Related Experiment Video
Updated: Jun 3, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Clinical experience with linezolid for the treatment of neurosurgical infections
D Sousa1, P Llinares, H Meijide
1Division of Infectious Diseases, Complejo Hospitalario Universitario A Coruña, Spain. dsoureg@sergas.es
Objectives:
We sought to evaluate the clinical use of linezolid for the treatment of neurosurgical infections.
Methods:
Retrospective observational study of a cohort of hospitalized patients who received linezolid for a culture-positive neurosurgical infection from July 2004 to February 2009 in a tertiary hospital in Spain.
Results:
Seventeen patients were included in the study. Main comorbidities among these patients included one or more of the following: subarachnoidal or intraventricular hemorrhage (n=8), solid neurological cancer (n=7), corticosteroids(n=9) and hydrocephalus (n=6). Eight patients underwent a craniotomy and fourteen patients had an external ventricular drainage (EVD) as predisposing factors for infection. Meningitis was the most common infection (11; 64.7%), followed by ventriculitis (4; 23.5%) and brain abscesses (2;11.8%). The main causative organisms were coagulase-negative Staphylococcus spp. (13; 76.5%). Linezolid was used as the initial therapy in 8 episodes, after therapy failure in 6 and for other reasons in 3. The oral route was used in 9 (52.9%) episodes; linezolid was initiated orally in 2 cases. The mean duration of treatment was 26.5 days (range 15-58). No adverse events were reported. Sixteen (94.1%) patients were considered cured.There was one recurrence. The mean length of hospital stay was 45.6 (range 15-112) days and the mean duration of follow-up was 7.2 (range 0.4-32) months. No related deaths occurred during active episodes.
Conclusions:
Linezolid was mainly indicated in post-neurosurgical EVD-associated infections due to coagulase-negative Staphylococcus spp. It was used as initial therapy in most cases. A high rate of clinical cure was observed and no related adverse events were reported. More than half of the patients were benefited by the advantages of the oral route of administration.
Insights
Linezolid effectively treated neurosurgical infections, primarily those linked to external ventricular drainage (EVD) and coagulase-negative Staphylococcus. This antibiotic demonstrated a high cure rate with no adverse events, showcasing the benefits of oral administration.
Area of Science:
- Infectious Diseases
- Neurosurgery
- Pharmacology
Background:
- Neurosurgical infections pose significant challenges due to patient comorbidities and invasive procedures.
- Coagulase-negative Staphylococcus species are common pathogens in these infections.
- Effective antibiotic therapy is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the clinical utility and effectiveness of linezolid in treating neurosurgical infections.
- To assess the safety and tolerability of linezolid in this patient population.
- To identify the main indications and outcomes associated with linezolid use.
Main Methods:
- Retrospective observational study of patients with culture-positive neurosurgical infections treated with linezolid.
- Data collected from July 2004 to February 2009 in a Spanish tertiary hospital.
- Analysis included patient demographics, comorbidities, infection types, causative organisms, treatment regimens, and clinical outcomes.
Main Results:
- Seventeen patients were included, with common comorbidities like hemorrhage, neurological cancer, and corticosteroid use.
- External ventricular drainage (EVD) and craniotomy were frequent predisposing factors.
- Coagulase-negative Staphylococcus spp. were the primary pathogens (76.5%).
- Linezolid achieved a high clinical cure rate (94.1%) with no reported adverse events.
- Oral administration was utilized in over half of the cases, facilitating treatment.
Conclusions:
- Linezolid is a valuable therapeutic option for post-neurosurgical infections, particularly EVD-associated infections caused by coagulase-negative Staphylococcus.
- The drug demonstrated a high clinical cure rate and an excellent safety profile in this cohort.
- The oral route of administration offers significant advantages for patient management.
Related Concept Videos
Local Anesthetics: Clinical Application as Spinal Anesthesia
Brain Abscess l: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...